Status:
TERMINATED
Tight Intra-Operative Glucose Control During Coronary Artery Bypass Surgery
Lead Sponsor:
Rabin Medical Center
Conditions:
Coronary Artery Bypass
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Blood glucose levels increase in response to stress, infection or other conditions faced by patients in the hospital. This occurs commonly among patients with known diabetes, but also among non-diabet...
Detailed Description
Current evidence supports intensive glucose control for patients in the intensive care unit post-cardiac surgery. The risk-benefit ratio of tight glucose control using continuous insulin infusion duri...
Eligibility Criteria
Inclusion
- All consecutive patients \>18 years undergoing CABG, without or without additional valve or other surgery at Rabin Medical Center; Beilinson campus, providing informed consent.
Exclusion
- Patients with diabetic ketoacidosis, or hyperosmolar coma
Key Trial Info
Start Date :
February 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2009
Estimated Enrollment :
1400 Patients enrolled
Trial Details
Trial ID
NCT00394303
Start Date
February 1 2007
End Date
August 1 2009
Last Update
April 1 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rabin Medical Center, Beilinson Hospital
Petah Tikvah, Israel, 49100